Q-Gel® CoQ10 passes the dissolution test and provides optimum relative bioavailability as evidenced in human, animal and in-vitro studies. We have the proof in the clinical trials. There are a number of clever ways that advertisers of many other types of CoQ10 market their product to get you to believe that …Read More
The following information is from a U.S. Government web site (the National Cancer Institute at the National Center for Complementary and Alternative Medicine
What is the history of the discovery and use of coenzyme Q10 as a complementary or alternative treatment for cancer?
Coenzyme Q10 …Read More
The effects of oral treatment with coenzyme Q10 (120 mg per day) were compared for 28 days in a randomized, double-blind placebo-controlled trial of coenzyme Q10 in patients with acute myocardial infarction.
The trial consisted of a total of 144 patients with acute myocardial infarction (AMI). 73 of the 144 patients were p …Read More
The global coenzyme Q10 (CoQ10) market is expected to reach USD 1.36 billion by 2024, according to a new report by Grand View Research, Inc. Increasing use in cosmetic formulations is a key driving factor for industry growth.
Asia Pacific is poised to be the fastest growing regional market …Read More
Systemic hypertension, (high blood pressure), affects more than 60 million adults in the United States. Worldwide, it is one of the most common risk factors for cardiovascular morbidity and mortality.
A randomized, double-blind, placebo-controlled clinical trial of Coenzyme Q10 in Isolated Systolic Hypertension was recently …Read More
In the November 2003 issue of Good Housekeeping, (page 83), leading heart surgeon Mehmet Oz, (Professor of Surgery at Columbia University College of Physicians & Surgeons and Attending Surgeon at Columbia Presbyterian Division of Cardiothoracic Surgery …Read More
A paper of a recent clinical study written by Fred L. Crane, (Department of Biological Science, Purdue University, W. Lafayette, Indiana) and Anna Gvozdjáková, (Comenius University, Bratislava, Slovakia), says yes and concludes that the “beneficial effect of ubiquinol in children with autism …Read More
Huntington’s Disease, (HD), is a genetic brain, (neurological), disease that affects both mind and body. Huntington’s Disease is characterized by an inability to control movements and an intellectual decline. The onset of …Read More
A study entitled: “Atorvastatin decreases the coenzyme Q10 level in the blood of patients at risk for cardiovascular disease and stroke” was published in June of 2004 in ARCH NEUROL / VOL 61, June 2004 page 889. The study concluded that even brief exposure to atorvastatin c …Read More
A randomized, double blind, placebo controlled trial was recently conducted to measure the effect of Q-Gel Coenzyme Q10 in patients with end stage heart failure. The results at the end of the twelve week trial were dramatically positive for the use of Q-Gel CoQ10 in patients with congestive heart failure and …Read More